imuflex wb-sp blood bag system with integral whole blood leukocyte reduction filter (saving platelets) with diversion blood sampling arm is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Terumo Corporation. The primary component is Dextrose Monohydrate; Trisodium Citrate Dihydrate; Anhydrous Citric Acid; Sodium Phosphate, Monobasic, Unspecified Form.
Product ID | 53877-010_6e111a6a-8eaa-4efa-88f5-61f06f5c1e46 |
NDC | 53877-010 |
Product Type | Human Prescription Drug |
Proprietary Name | imuflex wb-sp blood bag system with integral whole blood leukocyte reduction filter (saving platelets) with diversion blood sampling arm |
Generic Name | Anticoagulant Citrate Phosphate Dextrose (cpd) |
Dosage Form | Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2019-02-11 |
Marketing Category | NDA / NDA |
Application Number | BN880217 |
Labeler Name | Terumo Corporation |
Substance Name | DEXTROSE MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE; ANHYDROUS CITRIC ACID; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM |
Active Ingredient Strength | 2 g/70mL; g/70mL; mg/70mL; mg/70mL |
Pharm Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |